Midseptal and Anteroseptal Accessory Pathway Ablation in Children

László Környei1, Matevž Jan2, Mohammad Ebrahim3

  • 1Gottsegen National Cardiovascular Center, Hungarian Paediatric Heart Center, 1096 Budapest, Hungary.

PubMed

Insights

High-risk accessory pathways in children can be effectively treated with cryoablation or radiofrequency ablation using 3D mapping systems, minimizing radiation exposure and achieving high success rates.

Area of Science:

  • Cardiology
  • Pediatric Electrophysiology
  • Medical Technology

Background:

  • Accessory pathways (AP) in pediatric patients pose a risk for arrhythmias.
  • Minimizing fluoroscopy during ablation procedures is crucial in pediatric care.

Purpose of the Study:

  • To evaluate outcomes of ablation for high-risk accessory pathways in pediatric patients.
  • To assess the efficacy of 3D mapping systems with minimal fluoroscopy.

Main Methods:

  • A multicenter, cross-sectional study involving 111 pediatric patients (2013-2023).
  • Utilized 3D mapping systems (predominantly EnSite Precision™) for ablation.
  • Compared cryoablation (72.7%) and radiofrequency ablation (27.3%) for anteroseptal and midseptal pathways.

Main Results:

  • Overall acute success rate of 89.1% with a 17.2% recurrence rate.
  • No significant difference in success rates between anteroseptal and midseptal pathways or energy sources.
  • Low complication rate (4.69%) including transient AV block and hematoma. Minimal fluoroscopy used (mean 3 min 45 s).

Conclusions:

  • 3D mapping systems enable effective ablation of pediatric accessory pathways with low radiation doses.
  • Both radiofrequency and cryoablation are viable options with excellent acute success and low complication rates.